Logo image of LON.MI

LONGINO & CARDENAL - SPA (LON.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:LON - IT0005337073 - Common Stock

0.985 EUR
-0.03 (-2.48%)
Last: 11/17/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, LON scores 3 out of 10 in our fundamental rating. LON was compared to 57 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of LON is average, but there are quite some concerns on its profitability. LON has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year LON has reported negative net income.
LON had a positive operating cash flow in the past year.
In the past 5 years LON always reported negative net income.
In the past 5 years LON reported 4 times negative operating cash flow.
LON.MI Yearly Net Income VS EBIT VS OCF VS FCFLON.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M -3M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.90%, LON is doing worse than 68.42% of the companies in the same industry.
LON's Return On Equity of -8.57% is in line compared to the rest of the industry. LON outperforms 45.61% of its industry peers.
LON's Return On Invested Capital of 0.55% is on the low side compared to the rest of the industry. LON is outperformed by 70.18% of its industry peers.
Industry RankSector Rank
ROA -1.9%
ROE -8.57%
ROIC 0.55%
ROA(3y)-3.79%
ROA(5y)-5.08%
ROE(3y)-15.27%
ROE(5y)-17.43%
ROIC(3y)N/A
ROIC(5y)N/A
LON.MI Yearly ROA, ROE, ROICLON.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80 100

1.3 Margins

LON has a Operating Margin of 0.16%. This is in the lower half of the industry: LON underperforms 73.68% of its industry peers.
In the last couple of years the Operating Margin of LON has declined.
LON has a Gross Margin of 16.66%. This is in the lower half of the industry: LON underperforms 71.93% of its industry peers.
LON's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.16%
PM (TTM) N/A
GM 16.66%
OM growth 3YN/A
OM growth 5Y-47.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.93%
GM growth 5Y1.37%
LON.MI Yearly Profit, Operating, Gross MarginsLON.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

4

2. Health

2.1 Basic Checks

LON has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, LON has about the same amount of shares outstanding.
The number of shares outstanding for LON remains at a similar level compared to 5 years ago.
LON has a better debt/assets ratio than last year.
LON.MI Yearly Shares OutstandingLON.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
LON.MI Yearly Total Debt VS Total AssetsLON.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

An Altman-Z score of 2.34 indicates that LON is not a great score, but indicates only limited risk for bankruptcy at the moment.
LON's Altman-Z score of 2.34 is fine compared to the rest of the industry. LON outperforms 61.40% of its industry peers.
LON has a debt to FCF ratio of 10.09. This is a negative value and a sign of low solvency as LON would need 10.09 years to pay back of all of its debts.
LON has a Debt to FCF ratio of 10.09. This is in the lower half of the industry: LON underperforms 61.40% of its industry peers.
LON has a Debt/Equity ratio of 0.75. This is a neutral value indicating LON is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.75, LON is doing good in the industry, outperforming 70.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 10.09
Altman-Z 2.34
ROIC/WACC0.09
WACC5.81%
LON.MI Yearly LT Debt VS Equity VS FCFLON.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

A Current Ratio of 1.26 indicates that LON should not have too much problems paying its short term obligations.
The Current ratio of LON (1.26) is better than 78.95% of its industry peers.
LON has a Quick Ratio of 1.02. This is a normal value and indicates that LON is financially healthy and should not expect problems in meeting its short term obligations.
LON's Quick ratio of 1.02 is fine compared to the rest of the industry. LON outperforms 64.91% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.02
LON.MI Yearly Current Assets VS Current LiabilitesLON.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

3

3. Growth

3.1 Past

LON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -913.30%.
LON shows a decrease in Revenue. In the last year, the revenue decreased by -0.77%.
The Revenue has been growing slightly by 1.74% on average over the past years.
EPS 1Y (TTM)-913.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-508.31%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y11.77%
Revenue growth 5Y1.74%
Sales Q2Q%-4.4%

3.2 Future

Based on estimates for the next years, LON will show a very strong growth in Earnings Per Share. The EPS will grow by 72.61% on average per year.
The Revenue is expected to grow by 3.30% on average over the next years.
EPS Next Y-157.14%
EPS Next 2Y117.12%
EPS Next 3Y72.61%
EPS Next 5YN/A
Revenue Next Year-4.83%
Revenue Next 2Y-0.4%
Revenue Next 3Y1.93%
Revenue Next 5Y3.3%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LON.MI Yearly Revenue VS EstimatesLON.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M
LON.MI Yearly EPS VS EstimatesLON.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LON. In the last year negative earnings were reported.
LON is valuated reasonably with a Price/Forward Earnings ratio of 10.27.
Based on the Price/Forward Earnings ratio, LON is valued cheaply inside the industry as 84.21% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.59. LON is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 10.27
LON.MI Price Earnings VS Forward Price EarningsLON.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

LON's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LON indicates a rather cheap valuation: LON is cheaper than 80.70% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.81
EV/EBITDA 19.05
LON.MI Per share dataLON.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as LON's earnings are expected to grow with 72.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y117.12%
EPS Next 3Y72.61%

0

5. Dividend

5.1 Amount

LON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LONGINO & CARDENAL - SPA

BIT:LON (11/17/2025, 7:00:00 PM)

0.985

-0.03 (-2.48%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.16M
Revenue(TTM)36.76M
Net Income(TTM)-367.00K
Analysts80
Price Target2.53 (156.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-23.66%
PT rev (3m)-23.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-205.88%
EPS NY rev (3m)-175%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-9.21%
Revenue NY rev (3m)-10.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.27
P/S 0.16
P/FCF 7.81
P/OCF 6.06
P/B 1.44
P/tB 1.79
EV/EBITDA 19.05
EPS(TTM)-0.24
EYN/A
EPS(NY)0.1
Fwd EY9.74%
FCF(TTM)0.13
FCFY12.8%
OCF(TTM)0.16
OCFY16.51%
SpS6.01
BVpS0.69
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.9%
ROE -8.57%
ROCE 0.73%
ROIC 0.55%
ROICexc 0.72%
ROICexgc 0.83%
OM 0.16%
PM (TTM) N/A
GM 16.66%
FCFM 2.1%
ROA(3y)-3.79%
ROA(5y)-5.08%
ROE(3y)-15.27%
ROE(5y)-17.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-47.34%
ROICexc growth 3YN/A
ROICexc growth 5Y-46.53%
OM growth 3YN/A
OM growth 5Y-47.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.93%
GM growth 5Y1.37%
F-Score6
Asset Turnover1.94
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 10.09
Debt/EBITDA 4.99
Cap/Depr 39.28%
Cap/Sales 0.61%
Interest Coverage 250
Cash Conversion 158.88%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.02
Altman-Z 2.34
F-Score6
WACC5.81%
ROIC/WACC0.09
Cap/Depr(3y)89.53%
Cap/Depr(5y)161.15%
Cap/Sales(3y)1.76%
Cap/Sales(5y)3.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-913.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-508.31%
EPS Next Y-157.14%
EPS Next 2Y117.12%
EPS Next 3Y72.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y11.77%
Revenue growth 5Y1.74%
Sales Q2Q%-4.4%
Revenue Next Year-4.83%
Revenue Next 2Y-0.4%
Revenue Next 3Y1.93%
Revenue Next 5Y3.3%
EBIT growth 1Y-48.26%
EBIT growth 3YN/A
EBIT growth 5Y-46.44%
EBIT Next Year314.43%
EBIT Next 3Y84.55%
EBIT Next 5Y58.5%
FCF growth 1Y155.56%
FCF growth 3YN/A
FCF growth 5Y36.57%
OCF growth 1Y359.83%
OCF growth 3YN/A
OCF growth 5Y1.09%

LONGINO & CARDENAL - SPA / LON.MI FAQ

What is the fundamental rating for LON stock?

ChartMill assigns a fundamental rating of 3 / 10 to LON.MI.


What is the valuation status of LONGINO & CARDENAL - SPA (LON.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to LONGINO & CARDENAL - SPA (LON.MI). This can be considered as Fairly Valued.


How profitable is LONGINO & CARDENAL - SPA (LON.MI) stock?

LONGINO & CARDENAL - SPA (LON.MI) has a profitability rating of 1 / 10.


Is the dividend of LONGINO & CARDENAL - SPA sustainable?

The dividend rating of LONGINO & CARDENAL - SPA (LON.MI) is 0 / 10 and the dividend payout ratio is 0%.